Aktie A078650 G9PHARMA CO., LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen G9pharma co., LTD

Aktien

A078650

KR7078650009

A078650

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
G9pharma co., LTD Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
G9pharma co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2023
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2022
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
G9pharma co., LTD Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
G9pharma co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2022
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2021
G9pharma co., LTD cancelled the transaction announced on November 26, 2021
G9pharma co., LTD announced that it has received KRW 9.9999984 billion in funding from Meritz Securities Co., Ltd., Investment Arm, Cypress Partners Co., Ltd.
G9pharma co., LTD announced that it has received KRW 5.999999573 billion in funding from Meritz Securities Co., Ltd., Investment Arm
G9pharma co., LTD announced that it expects to receive KRW 1.5 billion in funding from Cypress Partners Co., Ltd.
G9pharma co., LTD announced that it has received KRW 9.99999775 billion in funding from Meritz Securities Co., Ltd., Investment Arm
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Mosaic Ventures, Luck & Trust Co., Ltd., Han International Co., Ltd., Hannam World and Medi Forum Co.,Ltd. completed the acquisition of 20.9% stake in Kolen Co., Ltd from Biolog Device Co., Ltd..
G9pharma co., LTD announced that it expects to receive KRW 17.99999925 billion in funding from Meritz Securities Co., Ltd., Investment Arm, Cypress Partners Co., Ltd.
Mosaic Ventures, Luck & Trust Co., Ltd., Han International Co., Ltd., Hannam World and Medi Forum Co.,Ltd. signed an agreement to acquire 20.9% stake in Kolen Co., Ltd from Biolog Device Co., Ltd. for KRW 15.5 billion.
G9pharma co., LTD announced that it expects to receive KRW 25.999999573 billion in funding from Meritz Securities Co., Ltd., Investment Arm
1EVOLUTION Marketing Research Inc. cancelled the acquisition of 99.99% stake in KOLEN PHILIPPINES INC from Kolen Co., Ltd.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A078650 Aktie
  4. Nachrichten G9pharma co., LTD
  5. Andere Sprachen